Thursday, July 24, 2025 5:34:16 AM
What's the story with it.. Near term Catalysts?
Recent TNFA News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/10/2025 09:26:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 10:51:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 09:30:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 09:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2025 09:29:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/06/2025 09:13:06 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/03/2025 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 09:28:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2025 09:10:36 PM
- Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS” • Business Wire • 09/25/2025 01:15:00 PM
- TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing • Business Wire • 09/24/2025 01:15:00 PM
- TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement • Business Wire • 09/17/2025 01:24:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2025 09:00:34 PM
- TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference • Business Wire • 09/08/2025 01:15:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2025 09:30:47 PM
- TNF Pharmaceuticals Announces Closing of $7 Million Private Placement • Business Wire • 09/04/2025 01:15:00 PM
- TNF Pharmaceuticals Shares Rise After Gaining Exclusive Crypto Computing Rights • IH Market News • 09/02/2025 02:13:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 01:29:14 PM
- TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications • Business Wire • 09/02/2025 01:15:00 PM
- TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance • Business Wire • 08/28/2025 01:15:00 PM
- TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation • Business Wire • 08/19/2025 09:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 09:15:52 PM
